Anhui Fengyuan Pharmaceutical Co Ltd (000153) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥69.15 Million ≈ $10.12 Million USD) by net assets (CN¥2.13 Billion ≈ $311.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Anhui Fengyuan Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.
Anhui Fengyuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Anhui Fengyuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Anhui Fengyuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anhui Fengyuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 000153 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
John Wiley & Sons B
NYSE:WLYB
|
0.185x |
|
Eupraxia Pharmaceuticals Inc
TO:EPRX
|
-0.037x |
|
LX Holdings Corp
KO:383800
|
-0.004x |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
0.040x |
|
Zhejiang Yueling Co Ltd
SHE:002725
|
0.008x |
|
MIDEA REAL HLDG HD 1
F:MR9
|
N/A |
|
Ningxia Younglight Chemicals Co Ltd
SHE:000635
|
0.008x |
|
Doright Co.Ltd.
SHE:300950
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Anhui Fengyuan Pharmaceutical Co Ltd from 1999 to 2025. View latest Anhui Fengyuan Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.13 Billion ≈ $311.10 Million |
CN¥119.30 Million ≈ $17.46 Million |
0.056x | -9.06% |
| 2024-12-31 | CN¥2.05 Billion ≈ $299.38 Million |
CN¥126.24 Million ≈ $18.47 Million |
0.062x | -53.53% |
| 2023-12-31 | CN¥1.92 Billion ≈ $280.78 Million |
CN¥254.75 Million ≈ $37.28 Million |
0.133x | -47.05% |
| 2022-12-31 | CN¥1.75 Billion ≈ $256.78 Million |
CN¥439.99 Million ≈ $64.38 Million |
0.251x | +64.19% |
| 2021-12-31 | CN¥1.56 Billion ≈ $227.94 Million |
CN¥237.88 Million ≈ $34.81 Million |
0.153x | -24.47% |
| 2020-12-31 | CN¥1.45 Billion ≈ $211.88 Million |
CN¥292.75 Million ≈ $42.84 Million |
0.202x | +305.23% |
| 2019-12-31 | CN¥1.33 Billion ≈ $194.20 Million |
CN¥66.21 Million ≈ $9.69 Million |
0.050x | -72.41% |
| 2018-12-31 | CN¥1.29 Billion ≈ $189.03 Million |
CN¥233.59 Million ≈ $34.18 Million |
0.181x | +321.21% |
| 2017-12-31 | CN¥1.22 Billion ≈ $178.59 Million |
CN¥52.40 Million ≈ $7.67 Million |
0.043x | -36.72% |
| 2016-12-31 | CN¥1.15 Billion ≈ $168.69 Million |
CN¥78.21 Million ≈ $11.44 Million |
0.068x | +76.59% |
| 2015-12-31 | CN¥1.18 Billion ≈ $173.29 Million |
CN¥45.50 Million ≈ $6.66 Million |
0.038x | +319.25% |
| 2014-12-31 | CN¥1.15 Billion ≈ $167.83 Million |
CN¥10.51 Million ≈ $1.54 Million |
0.009x | +113.74% |
| 2013-12-31 | CN¥1.05 Billion ≈ $154.28 Million |
CN¥-70.31 Million ≈ $-10.29 Million |
-0.067x | -213.22% |
| 2012-12-31 | CN¥775.01 Million ≈ $113.41 Million |
CN¥45.65 Million ≈ $6.68 Million |
0.059x | -18.14% |
| 2011-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥55.06 Million ≈ $8.06 Million |
0.072x | -1.45% |
| 2010-12-31 | CN¥753.81 Million ≈ $110.31 Million |
CN¥55.04 Million ≈ $8.05 Million |
0.073x | +52.92% |
| 2009-12-31 | CN¥678.70 Million ≈ $99.31 Million |
CN¥32.41 Million ≈ $4.74 Million |
0.048x | -37.32% |
| 2008-12-31 | CN¥654.09 Million ≈ $95.71 Million |
CN¥49.82 Million ≈ $7.29 Million |
0.076x | -11.93% |
| 2007-12-31 | CN¥638.89 Million ≈ $93.49 Million |
CN¥55.26 Million ≈ $8.09 Million |
0.086x | +47.97% |
| 2006-12-31 | CN¥620.49 Million ≈ $90.80 Million |
CN¥36.27 Million ≈ $5.31 Million |
0.058x | +0.49% |
| 2005-12-31 | CN¥599.59 Million ≈ $87.74 Million |
CN¥34.88 Million ≈ $5.10 Million |
0.058x | +393.43% |
| 2004-12-31 | CN¥591.07 Million ≈ $86.49 Million |
CN¥-11.72 Million ≈ $-1.71 Million |
-0.020x | +0.35% |
| 2003-12-31 | CN¥576.00 Million ≈ $84.29 Million |
CN¥-11.46 Million ≈ $-1.68 Million |
-0.020x | -206.51% |
| 2002-12-31 | CN¥560.87 Million ≈ $82.07 Million |
CN¥10.48 Million ≈ $1.53 Million |
0.019x | -57.51% |
| 2001-12-31 | CN¥536.15 Million ≈ $78.46 Million |
CN¥23.57 Million ≈ $3.45 Million |
0.044x | -9.55% |
| 2000-12-31 | CN¥532.50 Million ≈ $77.92 Million |
CN¥25.88 Million ≈ $3.79 Million |
0.049x | +154.14% |
| 1999-12-31 | CN¥52.98 Million ≈ $7.75 Million |
CN¥1.01 Million ≈ $148.25K |
0.019x | -- |
About Anhui Fengyuan Pharmaceutical Co Ltd
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells medicines in China. The company also exports its products. Anhui Fengyuan Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Hefei, China.